Global Peripheral Drug-Coated Balloon Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Peripheral Drug-Coated Balloon market size was valued at US$ 844.2 million in 2023. With growing demand in downstream market, the Peripheral Drug-Coated Balloon is forecast to a readjusted size of US$ 1360.5 million by 2030 with a CAGR of 7.1% during review period.
The research report highlights the growth potential of the global Peripheral Drug-Coated Balloon market. Peripheral Drug-Coated Balloon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Peripheral Drug-Coated Balloon. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Peripheral Drug-Coated Balloon market.
Drug-coated balloons (DCB) have been introduced to improve patency rates following endovascular intervention for lower extremity PAD. They have gained popularity among endovascular specialists due to its ease of use and the concept of “leave nothing behind”.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Peripheral Drug-Coated Balloon market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Peripheral Drug-Coated Balloon market. It may include historical data, market segmentation by Type (e.g., Paclitaxel, Sirolimus), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Peripheral Drug-Coated Balloon market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Peripheral Drug-Coated Balloon market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Peripheral Drug-Coated Balloon industry. This include advancements in Peripheral Drug-Coated Balloon technology, Peripheral Drug-Coated Balloon new entrants, Peripheral Drug-Coated Balloon new investment, and other innovations that are shaping the future of Peripheral Drug-Coated Balloon.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Peripheral Drug-Coated Balloon market. It includes factors influencing customer ' purchasing decisions, preferences for Peripheral Drug-Coated Balloon product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Peripheral Drug-Coated Balloon market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Peripheral Drug-Coated Balloon market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Peripheral Drug-Coated Balloon market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Peripheral Drug-Coated Balloon industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Peripheral Drug-Coated Balloon market.
Market Segmentation:
Peripheral Drug-Coated Balloon market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Peripheral Drug-Coated Balloon market?
What factors are driving Peripheral Drug-Coated Balloon market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Peripheral Drug-Coated Balloon market opportunities vary by end market size?
How does Peripheral Drug-Coated Balloon break out type, application?
According to our LPI (LP Information) latest study, the global Peripheral Drug-Coated Balloon market size was valued at US$ 844.2 million in 2023. With growing demand in downstream market, the Peripheral Drug-Coated Balloon is forecast to a readjusted size of US$ 1360.5 million by 2030 with a CAGR of 7.1% during review period.
The research report highlights the growth potential of the global Peripheral Drug-Coated Balloon market. Peripheral Drug-Coated Balloon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Peripheral Drug-Coated Balloon. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Peripheral Drug-Coated Balloon market.
Drug-coated balloons (DCB) have been introduced to improve patency rates following endovascular intervention for lower extremity PAD. They have gained popularity among endovascular specialists due to its ease of use and the concept of “leave nothing behind”.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Peripheral Drug-Coated Balloon market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Peripheral Drug-Coated Balloon market. It may include historical data, market segmentation by Type (e.g., Paclitaxel, Sirolimus), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Peripheral Drug-Coated Balloon market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Peripheral Drug-Coated Balloon market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Peripheral Drug-Coated Balloon industry. This include advancements in Peripheral Drug-Coated Balloon technology, Peripheral Drug-Coated Balloon new entrants, Peripheral Drug-Coated Balloon new investment, and other innovations that are shaping the future of Peripheral Drug-Coated Balloon.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Peripheral Drug-Coated Balloon market. It includes factors influencing customer ' purchasing decisions, preferences for Peripheral Drug-Coated Balloon product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Peripheral Drug-Coated Balloon market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Peripheral Drug-Coated Balloon market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Peripheral Drug-Coated Balloon market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Peripheral Drug-Coated Balloon industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Peripheral Drug-Coated Balloon market.
Market Segmentation:
Peripheral Drug-Coated Balloon market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Paclitaxel
- Sirolimus
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cordis
- Defibtech
- Abbott Laboratories
- REVA Medical
- Shimadzu
- Opto Circuits
- Biotronik
- Endologix
- SMT
- Philips Healthcare
- Elixir Medical
- CorMatrix Cardiovascular
- Advanced Cardiac Therapeutics
- Edwards Lifesciences
- Impulse Dynamics
- Stereotaxis
What is the 10-year outlook for the global Peripheral Drug-Coated Balloon market?
What factors are driving Peripheral Drug-Coated Balloon market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Peripheral Drug-Coated Balloon market opportunities vary by end market size?
How does Peripheral Drug-Coated Balloon break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peripheral Drug-Coated Balloon Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Peripheral Drug-Coated Balloon by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Peripheral Drug-Coated Balloon by Country/Region, 2019, 2023 & 2030
2.2 Peripheral Drug-Coated Balloon Segment by Type
2.2.1 Paclitaxel
2.2.2 Sirolimus
2.2.3 Others
2.3 Peripheral Drug-Coated Balloon Sales by Type
2.3.1 Global Peripheral Drug-Coated Balloon Sales Market Share by Type (2019-2024)
2.3.2 Global Peripheral Drug-Coated Balloon Revenue and Market Share by Type (2019-2024)
2.3.3 Global Peripheral Drug-Coated Balloon Sale Price by Type (2019-2024)
2.4 Peripheral Drug-Coated Balloon Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Peripheral Drug-Coated Balloon Sales by Application
2.5.1 Global Peripheral Drug-Coated Balloon Sale Market Share by Application (2019-2024)
2.5.2 Global Peripheral Drug-Coated Balloon Revenue and Market Share by Application (2019-2024)
2.5.3 Global Peripheral Drug-Coated Balloon Sale Price by Application (2019-2024)
3 GLOBAL PERIPHERAL DRUG-COATED BALLOON BY COMPANY
3.1 Global Peripheral Drug-Coated Balloon Breakdown Data by Company
3.1.1 Global Peripheral Drug-Coated Balloon Annual Sales by Company (2019-2024)
3.1.2 Global Peripheral Drug-Coated Balloon Sales Market Share by Company (2019-2024)
3.2 Global Peripheral Drug-Coated Balloon Annual Revenue by Company (2019-2024)
3.2.1 Global Peripheral Drug-Coated Balloon Revenue by Company (2019-2024)
3.2.2 Global Peripheral Drug-Coated Balloon Revenue Market Share by Company (2019-2024)
3.3 Global Peripheral Drug-Coated Balloon Sale Price by Company
3.4 Key Manufacturers Peripheral Drug-Coated Balloon Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peripheral Drug-Coated Balloon Product Location Distribution
3.4.2 Players Peripheral Drug-Coated Balloon Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PERIPHERAL DRUG-COATED BALLOON BY GEOGRAPHIC REGION
4.1 World Historic Peripheral Drug-Coated Balloon Market Size by Geographic Region (2019-2024)
4.1.1 Global Peripheral Drug-Coated Balloon Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Peripheral Drug-Coated Balloon Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Peripheral Drug-Coated Balloon Market Size by Country/Region (2019-2024)
4.2.1 Global Peripheral Drug-Coated Balloon Annual Sales by Country/Region (2019-2024)
4.2.2 Global Peripheral Drug-Coated Balloon Annual Revenue by Country/Region (2019-2024)
4.3 Americas Peripheral Drug-Coated Balloon Sales Growth
4.4 APAC Peripheral Drug-Coated Balloon Sales Growth
4.5 Europe Peripheral Drug-Coated Balloon Sales Growth
4.6 Middle East & Africa Peripheral Drug-Coated Balloon Sales Growth
5 AMERICAS
5.1 Americas Peripheral Drug-Coated Balloon Sales by Country
5.1.1 Americas Peripheral Drug-Coated Balloon Sales by Country (2019-2024)
5.1.2 Americas Peripheral Drug-Coated Balloon Revenue by Country (2019-2024)
5.2 Americas Peripheral Drug-Coated Balloon Sales by Type
5.3 Americas Peripheral Drug-Coated Balloon Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral Drug-Coated Balloon Sales by Region
6.1.1 APAC Peripheral Drug-Coated Balloon Sales by Region (2019-2024)
6.1.2 APAC Peripheral Drug-Coated Balloon Revenue by Region (2019-2024)
6.2 APAC Peripheral Drug-Coated Balloon Sales by Type
6.3 APAC Peripheral Drug-Coated Balloon Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Peripheral Drug-Coated Balloon by Country
7.1.1 Europe Peripheral Drug-Coated Balloon Sales by Country (2019-2024)
7.1.2 Europe Peripheral Drug-Coated Balloon Revenue by Country (2019-2024)
7.2 Europe Peripheral Drug-Coated Balloon Sales by Type
7.3 Europe Peripheral Drug-Coated Balloon Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peripheral Drug-Coated Balloon by Country
8.1.1 Middle East & Africa Peripheral Drug-Coated Balloon Sales by Country (2019-2024)
8.1.2 Middle East & Africa Peripheral Drug-Coated Balloon Revenue by Country (2019-2024)
8.2 Middle East & Africa Peripheral Drug-Coated Balloon Sales by Type
8.3 Middle East & Africa Peripheral Drug-Coated Balloon Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Peripheral Drug-Coated Balloon
10.3 Manufacturing Process Analysis of Peripheral Drug-Coated Balloon
10.4 Industry Chain Structure of Peripheral Drug-Coated Balloon
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Peripheral Drug-Coated Balloon Distributors
11.3 Peripheral Drug-Coated Balloon Customer
12 WORLD FORECAST REVIEW FOR PERIPHERAL DRUG-COATED BALLOON BY GEOGRAPHIC REGION
12.1 Global Peripheral Drug-Coated Balloon Market Size Forecast by Region
12.1.1 Global Peripheral Drug-Coated Balloon Forecast by Region (2025-2030)
12.1.2 Global Peripheral Drug-Coated Balloon Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Peripheral Drug-Coated Balloon Forecast by Type
12.7 Global Peripheral Drug-Coated Balloon Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Cordis
13.1.1 Cordis Company Information
13.1.2 Cordis Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.1.3 Cordis Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Cordis Main Business Overview
13.1.5 Cordis Latest Developments
13.2 Defibtech
13.2.1 Defibtech Company Information
13.2.2 Defibtech Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.2.3 Defibtech Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Defibtech Main Business Overview
13.2.5 Defibtech Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.3.3 Abbott Laboratories Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 REVA Medical
13.4.1 REVA Medical Company Information
13.4.2 REVA Medical Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.4.3 REVA Medical Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 REVA Medical Main Business Overview
13.4.5 REVA Medical Latest Developments
13.5 Shimadzu
13.5.1 Shimadzu Company Information
13.5.2 Shimadzu Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.5.3 Shimadzu Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Shimadzu Main Business Overview
13.5.5 Shimadzu Latest Developments
13.6 Opto Circuits
13.6.1 Opto Circuits Company Information
13.6.2 Opto Circuits Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.6.3 Opto Circuits Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Opto Circuits Main Business Overview
13.6.5 Opto Circuits Latest Developments
13.7 Biotronik
13.7.1 Biotronik Company Information
13.7.2 Biotronik Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.7.3 Biotronik Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Biotronik Main Business Overview
13.7.5 Biotronik Latest Developments
13.8 Endologix
13.8.1 Endologix Company Information
13.8.2 Endologix Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.8.3 Endologix Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Endologix Main Business Overview
13.8.5 Endologix Latest Developments
13.9 SMT
13.9.1 SMT Company Information
13.9.2 SMT Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.9.3 SMT Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 SMT Main Business Overview
13.9.5 SMT Latest Developments
13.10 Philips Healthcare
13.10.1 Philips Healthcare Company Information
13.10.2 Philips Healthcare Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.10.3 Philips Healthcare Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Philips Healthcare Main Business Overview
13.10.5 Philips Healthcare Latest Developments
13.11 Elixir Medical
13.11.1 Elixir Medical Company Information
13.11.2 Elixir Medical Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.11.3 Elixir Medical Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Elixir Medical Main Business Overview
13.11.5 Elixir Medical Latest Developments
13.12 CorMatrix Cardiovascular
13.12.1 CorMatrix Cardiovascular Company Information
13.12.2 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.12.3 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 CorMatrix Cardiovascular Main Business Overview
13.12.5 CorMatrix Cardiovascular Latest Developments
13.13 Advanced Cardiac Therapeutics
13.13.1 Advanced Cardiac Therapeutics Company Information
13.13.2 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.13.3 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Advanced Cardiac Therapeutics Main Business Overview
13.13.5 Advanced Cardiac Therapeutics Latest Developments
13.14 Edwards Lifesciences
13.14.1 Edwards Lifesciences Company Information
13.14.2 Edwards Lifesciences Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.14.3 Edwards Lifesciences Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Edwards Lifesciences Main Business Overview
13.14.5 Edwards Lifesciences Latest Developments
13.15 Impulse Dynamics
13.15.1 Impulse Dynamics Company Information
13.15.2 Impulse Dynamics Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.15.3 Impulse Dynamics Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Impulse Dynamics Main Business Overview
13.15.5 Impulse Dynamics Latest Developments
13.16 Stereotaxis
13.16.1 Stereotaxis Company Information
13.16.2 Stereotaxis Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.16.3 Stereotaxis Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Stereotaxis Main Business Overview
13.16.5 Stereotaxis Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peripheral Drug-Coated Balloon Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Peripheral Drug-Coated Balloon by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Peripheral Drug-Coated Balloon by Country/Region, 2019, 2023 & 2030
2.2 Peripheral Drug-Coated Balloon Segment by Type
2.2.1 Paclitaxel
2.2.2 Sirolimus
2.2.3 Others
2.3 Peripheral Drug-Coated Balloon Sales by Type
2.3.1 Global Peripheral Drug-Coated Balloon Sales Market Share by Type (2019-2024)
2.3.2 Global Peripheral Drug-Coated Balloon Revenue and Market Share by Type (2019-2024)
2.3.3 Global Peripheral Drug-Coated Balloon Sale Price by Type (2019-2024)
2.4 Peripheral Drug-Coated Balloon Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Peripheral Drug-Coated Balloon Sales by Application
2.5.1 Global Peripheral Drug-Coated Balloon Sale Market Share by Application (2019-2024)
2.5.2 Global Peripheral Drug-Coated Balloon Revenue and Market Share by Application (2019-2024)
2.5.3 Global Peripheral Drug-Coated Balloon Sale Price by Application (2019-2024)
3 GLOBAL PERIPHERAL DRUG-COATED BALLOON BY COMPANY
3.1 Global Peripheral Drug-Coated Balloon Breakdown Data by Company
3.1.1 Global Peripheral Drug-Coated Balloon Annual Sales by Company (2019-2024)
3.1.2 Global Peripheral Drug-Coated Balloon Sales Market Share by Company (2019-2024)
3.2 Global Peripheral Drug-Coated Balloon Annual Revenue by Company (2019-2024)
3.2.1 Global Peripheral Drug-Coated Balloon Revenue by Company (2019-2024)
3.2.2 Global Peripheral Drug-Coated Balloon Revenue Market Share by Company (2019-2024)
3.3 Global Peripheral Drug-Coated Balloon Sale Price by Company
3.4 Key Manufacturers Peripheral Drug-Coated Balloon Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peripheral Drug-Coated Balloon Product Location Distribution
3.4.2 Players Peripheral Drug-Coated Balloon Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PERIPHERAL DRUG-COATED BALLOON BY GEOGRAPHIC REGION
4.1 World Historic Peripheral Drug-Coated Balloon Market Size by Geographic Region (2019-2024)
4.1.1 Global Peripheral Drug-Coated Balloon Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Peripheral Drug-Coated Balloon Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Peripheral Drug-Coated Balloon Market Size by Country/Region (2019-2024)
4.2.1 Global Peripheral Drug-Coated Balloon Annual Sales by Country/Region (2019-2024)
4.2.2 Global Peripheral Drug-Coated Balloon Annual Revenue by Country/Region (2019-2024)
4.3 Americas Peripheral Drug-Coated Balloon Sales Growth
4.4 APAC Peripheral Drug-Coated Balloon Sales Growth
4.5 Europe Peripheral Drug-Coated Balloon Sales Growth
4.6 Middle East & Africa Peripheral Drug-Coated Balloon Sales Growth
5 AMERICAS
5.1 Americas Peripheral Drug-Coated Balloon Sales by Country
5.1.1 Americas Peripheral Drug-Coated Balloon Sales by Country (2019-2024)
5.1.2 Americas Peripheral Drug-Coated Balloon Revenue by Country (2019-2024)
5.2 Americas Peripheral Drug-Coated Balloon Sales by Type
5.3 Americas Peripheral Drug-Coated Balloon Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral Drug-Coated Balloon Sales by Region
6.1.1 APAC Peripheral Drug-Coated Balloon Sales by Region (2019-2024)
6.1.2 APAC Peripheral Drug-Coated Balloon Revenue by Region (2019-2024)
6.2 APAC Peripheral Drug-Coated Balloon Sales by Type
6.3 APAC Peripheral Drug-Coated Balloon Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Peripheral Drug-Coated Balloon by Country
7.1.1 Europe Peripheral Drug-Coated Balloon Sales by Country (2019-2024)
7.1.2 Europe Peripheral Drug-Coated Balloon Revenue by Country (2019-2024)
7.2 Europe Peripheral Drug-Coated Balloon Sales by Type
7.3 Europe Peripheral Drug-Coated Balloon Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peripheral Drug-Coated Balloon by Country
8.1.1 Middle East & Africa Peripheral Drug-Coated Balloon Sales by Country (2019-2024)
8.1.2 Middle East & Africa Peripheral Drug-Coated Balloon Revenue by Country (2019-2024)
8.2 Middle East & Africa Peripheral Drug-Coated Balloon Sales by Type
8.3 Middle East & Africa Peripheral Drug-Coated Balloon Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Peripheral Drug-Coated Balloon
10.3 Manufacturing Process Analysis of Peripheral Drug-Coated Balloon
10.4 Industry Chain Structure of Peripheral Drug-Coated Balloon
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Peripheral Drug-Coated Balloon Distributors
11.3 Peripheral Drug-Coated Balloon Customer
12 WORLD FORECAST REVIEW FOR PERIPHERAL DRUG-COATED BALLOON BY GEOGRAPHIC REGION
12.1 Global Peripheral Drug-Coated Balloon Market Size Forecast by Region
12.1.1 Global Peripheral Drug-Coated Balloon Forecast by Region (2025-2030)
12.1.2 Global Peripheral Drug-Coated Balloon Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Peripheral Drug-Coated Balloon Forecast by Type
12.7 Global Peripheral Drug-Coated Balloon Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Cordis
13.1.1 Cordis Company Information
13.1.2 Cordis Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.1.3 Cordis Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Cordis Main Business Overview
13.1.5 Cordis Latest Developments
13.2 Defibtech
13.2.1 Defibtech Company Information
13.2.2 Defibtech Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.2.3 Defibtech Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Defibtech Main Business Overview
13.2.5 Defibtech Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.3.3 Abbott Laboratories Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 REVA Medical
13.4.1 REVA Medical Company Information
13.4.2 REVA Medical Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.4.3 REVA Medical Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 REVA Medical Main Business Overview
13.4.5 REVA Medical Latest Developments
13.5 Shimadzu
13.5.1 Shimadzu Company Information
13.5.2 Shimadzu Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.5.3 Shimadzu Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Shimadzu Main Business Overview
13.5.5 Shimadzu Latest Developments
13.6 Opto Circuits
13.6.1 Opto Circuits Company Information
13.6.2 Opto Circuits Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.6.3 Opto Circuits Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Opto Circuits Main Business Overview
13.6.5 Opto Circuits Latest Developments
13.7 Biotronik
13.7.1 Biotronik Company Information
13.7.2 Biotronik Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.7.3 Biotronik Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Biotronik Main Business Overview
13.7.5 Biotronik Latest Developments
13.8 Endologix
13.8.1 Endologix Company Information
13.8.2 Endologix Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.8.3 Endologix Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Endologix Main Business Overview
13.8.5 Endologix Latest Developments
13.9 SMT
13.9.1 SMT Company Information
13.9.2 SMT Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.9.3 SMT Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 SMT Main Business Overview
13.9.5 SMT Latest Developments
13.10 Philips Healthcare
13.10.1 Philips Healthcare Company Information
13.10.2 Philips Healthcare Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.10.3 Philips Healthcare Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Philips Healthcare Main Business Overview
13.10.5 Philips Healthcare Latest Developments
13.11 Elixir Medical
13.11.1 Elixir Medical Company Information
13.11.2 Elixir Medical Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.11.3 Elixir Medical Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Elixir Medical Main Business Overview
13.11.5 Elixir Medical Latest Developments
13.12 CorMatrix Cardiovascular
13.12.1 CorMatrix Cardiovascular Company Information
13.12.2 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.12.3 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 CorMatrix Cardiovascular Main Business Overview
13.12.5 CorMatrix Cardiovascular Latest Developments
13.13 Advanced Cardiac Therapeutics
13.13.1 Advanced Cardiac Therapeutics Company Information
13.13.2 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.13.3 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Advanced Cardiac Therapeutics Main Business Overview
13.13.5 Advanced Cardiac Therapeutics Latest Developments
13.14 Edwards Lifesciences
13.14.1 Edwards Lifesciences Company Information
13.14.2 Edwards Lifesciences Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.14.3 Edwards Lifesciences Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Edwards Lifesciences Main Business Overview
13.14.5 Edwards Lifesciences Latest Developments
13.15 Impulse Dynamics
13.15.1 Impulse Dynamics Company Information
13.15.2 Impulse Dynamics Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.15.3 Impulse Dynamics Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Impulse Dynamics Main Business Overview
13.15.5 Impulse Dynamics Latest Developments
13.16 Stereotaxis
13.16.1 Stereotaxis Company Information
13.16.2 Stereotaxis Peripheral Drug-Coated Balloon Product Portfolios and Specifications
13.16.3 Stereotaxis Peripheral Drug-Coated Balloon Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Stereotaxis Main Business Overview
13.16.5 Stereotaxis Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Peripheral Drug-Coated Balloon Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Peripheral Drug-Coated Balloon Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Paclitaxel
Table 4. Major Players of Sirolimus
Table 5. Major Players of Others
Table 6. Global Peripheral Drug-Coated Balloon Sales by Type (2019-2024) & (K Units)
Table 7. Global Peripheral Drug-Coated Balloon Sales Market Share by Type (2019-2024)
Table 8. Global Peripheral Drug-Coated Balloon Revenue by Type (2019-2024) & ($ million)
Table 9. Global Peripheral Drug-Coated Balloon Revenue Market Share by Type (2019-2024)
Table 10. Global Peripheral Drug-Coated Balloon Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Peripheral Drug-Coated Balloon Sales by Application (2019-2024) & (K Units)
Table 12. Global Peripheral Drug-Coated Balloon Sales Market Share by Application (2019-2024)
Table 13. Global Peripheral Drug-Coated Balloon Revenue by Application (2019-2024)
Table 14. Global Peripheral Drug-Coated Balloon Revenue Market Share by Application (2019-2024)
Table 15. Global Peripheral Drug-Coated Balloon Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Peripheral Drug-Coated Balloon Sales by Company (2019-2024) & (K Units)
Table 17. Global Peripheral Drug-Coated Balloon Sales Market Share by Company (2019-2024)
Table 18. Global Peripheral Drug-Coated Balloon Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Peripheral Drug-Coated Balloon Revenue Market Share by Company (2019-2024)
Table 20. Global Peripheral Drug-Coated Balloon Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Peripheral Drug-Coated Balloon Producing Area Distribution and Sales Area
Table 22. Players Peripheral Drug-Coated Balloon Products Offered
Table 23. Peripheral Drug-Coated Balloon Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Peripheral Drug-Coated Balloon Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Peripheral Drug-Coated Balloon Sales Market Share Geographic Region (2019-2024)
Table 28. Global Peripheral Drug-Coated Balloon Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Peripheral Drug-Coated Balloon Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Peripheral Drug-Coated Balloon Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Peripheral Drug-Coated Balloon Sales Market Share by Country/Region (2019-2024)
Table 32. Global Peripheral Drug-Coated Balloon Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Peripheral Drug-Coated Balloon Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Peripheral Drug-Coated Balloon Sales by Country (2019-2024) & (K Units)
Table 35. Americas Peripheral Drug-Coated Balloon Sales Market Share by Country (2019-2024)
Table 36. Americas Peripheral Drug-Coated Balloon Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Peripheral Drug-Coated Balloon Revenue Market Share by Country (2019-2024)
Table 38. Americas Peripheral Drug-Coated Balloon Sales by Type (2019-2024) & (K Units)
Table 39. Americas Peripheral Drug-Coated Balloon Sales by Application (2019-2024) & (K Units)
Table 40. APAC Peripheral Drug-Coated Balloon Sales by Region (2019-2024) & (K Units)
Table 41. APAC Peripheral Drug-Coated Balloon Sales Market Share by Region (2019-2024)
Table 42. APAC Peripheral Drug-Coated Balloon Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Peripheral Drug-Coated Balloon Revenue Market Share by Region (2019-2024)
Table 44. APAC Peripheral Drug-Coated Balloon Sales by Type (2019-2024) & (K Units)
Table 45. APAC Peripheral Drug-Coated Balloon Sales by Application (2019-2024) & (K Units)
Table 46. Europe Peripheral Drug-Coated Balloon Sales by Country (2019-2024) & (K Units)
Table 47. Europe Peripheral Drug-Coated Balloon Sales Market Share by Country (2019-2024)
Table 48. Europe Peripheral Drug-Coated Balloon Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Peripheral Drug-Coated Balloon Revenue Market Share by Country (2019-2024)
Table 50. Europe Peripheral Drug-Coated Balloon Sales by Type (2019-2024) & (K Units)
Table 51. Europe Peripheral Drug-Coated Balloon Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Peripheral Drug-Coated Balloon Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Peripheral Drug-Coated Balloon Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Peripheral Drug-Coated Balloon
Table 59. Key Market Challenges & Risks of Peripheral Drug-Coated Balloon
Table 60. Key Industry Trends of Peripheral Drug-Coated Balloon
Table 61. Peripheral Drug-Coated Balloon Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Peripheral Drug-Coated Balloon Distributors List
Table 64. Peripheral Drug-Coated Balloon Customer List
Table 65. Global Peripheral Drug-Coated Balloon Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Peripheral Drug-Coated Balloon Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Peripheral Drug-Coated Balloon Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Peripheral Drug-Coated Balloon Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Peripheral Drug-Coated Balloon Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Peripheral Drug-Coated Balloon Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Peripheral Drug-Coated Balloon Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Peripheral Drug-Coated Balloon Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Peripheral Drug-Coated Balloon Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Peripheral Drug-Coated Balloon Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Peripheral Drug-Coated Balloon Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Peripheral Drug-Coated Balloon Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Peripheral Drug-Coated Balloon Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Peripheral Drug-Coated Balloon Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Cordis Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 80. Cordis Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 81. Cordis Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Cordis Main Business
Table 83. Cordis Latest Developments
Table 84. Defibtech Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 85. Defibtech Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 86. Defibtech Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Defibtech Main Business
Table 88. Defibtech Latest Developments
Table 89. Abbott Laboratories Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 90. Abbott Laboratories Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 91. Abbott Laboratories Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Abbott Laboratories Main Business
Table 93. Abbott Laboratories Latest Developments
Table 94. REVA Medical Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 95. REVA Medical Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 96. REVA Medical Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. REVA Medical Main Business
Table 98. REVA Medical Latest Developments
Table 99. Shimadzu Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 100. Shimadzu Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 101. Shimadzu Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. Shimadzu Main Business
Table 103. Shimadzu Latest Developments
Table 104. Opto Circuits Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 105. Opto Circuits Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 106. Opto Circuits Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. Opto Circuits Main Business
Table 108. Opto Circuits Latest Developments
Table 109. Biotronik Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 110. Biotronik Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 111. Biotronik Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Biotronik Main Business
Table 113. Biotronik Latest Developments
Table 114. Endologix Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 115. Endologix Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 116. Endologix Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. Endologix Main Business
Table 118. Endologix Latest Developments
Table 119. SMT Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 120. SMT Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 121. SMT Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. SMT Main Business
Table 123. SMT Latest Developments
Table 124. Philips Healthcare Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 125. Philips Healthcare Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 126. Philips Healthcare Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. Philips Healthcare Main Business
Table 128. Philips Healthcare Latest Developments
Table 129. Elixir Medical Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 130. Elixir Medical Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 131. Elixir Medical Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. Elixir Medical Main Business
Table 133. Elixir Medical Latest Developments
Table 134. CorMatrix Cardiovascular Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 135. CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 136. CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 137. CorMatrix Cardiovascular Main Business
Table 138. CorMatrix Cardiovascular Latest Developments
Table 139. Advanced Cardiac Therapeutics Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 140. Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 141. Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 142. Advanced Cardiac Therapeutics Main Business
Table 143. Advanced Cardiac Therapeutics Latest Developments
Table 144. Edwards Lifesciences Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 145. Edwards Lifesciences Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 146. Edwards Lifesciences Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 147. Edwards Lifesciences Main Business
Table 148. Edwards Lifesciences Latest Developments
Table 149. Impulse Dynamics Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 150. Impulse Dynamics Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 151. Impulse Dynamics Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 152. Impulse Dynamics Main Business
Table 153. Impulse Dynamics Latest Developments
Table 154. Stereotaxis Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 155. Stereotaxis Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 156. Stereotaxis Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 157. Stereotaxis Main Business
Table 158. Stereotaxis Latest Developments
Table 1. Peripheral Drug-Coated Balloon Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Peripheral Drug-Coated Balloon Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Paclitaxel
Table 4. Major Players of Sirolimus
Table 5. Major Players of Others
Table 6. Global Peripheral Drug-Coated Balloon Sales by Type (2019-2024) & (K Units)
Table 7. Global Peripheral Drug-Coated Balloon Sales Market Share by Type (2019-2024)
Table 8. Global Peripheral Drug-Coated Balloon Revenue by Type (2019-2024) & ($ million)
Table 9. Global Peripheral Drug-Coated Balloon Revenue Market Share by Type (2019-2024)
Table 10. Global Peripheral Drug-Coated Balloon Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Peripheral Drug-Coated Balloon Sales by Application (2019-2024) & (K Units)
Table 12. Global Peripheral Drug-Coated Balloon Sales Market Share by Application (2019-2024)
Table 13. Global Peripheral Drug-Coated Balloon Revenue by Application (2019-2024)
Table 14. Global Peripheral Drug-Coated Balloon Revenue Market Share by Application (2019-2024)
Table 15. Global Peripheral Drug-Coated Balloon Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Peripheral Drug-Coated Balloon Sales by Company (2019-2024) & (K Units)
Table 17. Global Peripheral Drug-Coated Balloon Sales Market Share by Company (2019-2024)
Table 18. Global Peripheral Drug-Coated Balloon Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Peripheral Drug-Coated Balloon Revenue Market Share by Company (2019-2024)
Table 20. Global Peripheral Drug-Coated Balloon Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Peripheral Drug-Coated Balloon Producing Area Distribution and Sales Area
Table 22. Players Peripheral Drug-Coated Balloon Products Offered
Table 23. Peripheral Drug-Coated Balloon Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Peripheral Drug-Coated Balloon Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Peripheral Drug-Coated Balloon Sales Market Share Geographic Region (2019-2024)
Table 28. Global Peripheral Drug-Coated Balloon Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Peripheral Drug-Coated Balloon Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Peripheral Drug-Coated Balloon Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Peripheral Drug-Coated Balloon Sales Market Share by Country/Region (2019-2024)
Table 32. Global Peripheral Drug-Coated Balloon Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Peripheral Drug-Coated Balloon Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Peripheral Drug-Coated Balloon Sales by Country (2019-2024) & (K Units)
Table 35. Americas Peripheral Drug-Coated Balloon Sales Market Share by Country (2019-2024)
Table 36. Americas Peripheral Drug-Coated Balloon Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Peripheral Drug-Coated Balloon Revenue Market Share by Country (2019-2024)
Table 38. Americas Peripheral Drug-Coated Balloon Sales by Type (2019-2024) & (K Units)
Table 39. Americas Peripheral Drug-Coated Balloon Sales by Application (2019-2024) & (K Units)
Table 40. APAC Peripheral Drug-Coated Balloon Sales by Region (2019-2024) & (K Units)
Table 41. APAC Peripheral Drug-Coated Balloon Sales Market Share by Region (2019-2024)
Table 42. APAC Peripheral Drug-Coated Balloon Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Peripheral Drug-Coated Balloon Revenue Market Share by Region (2019-2024)
Table 44. APAC Peripheral Drug-Coated Balloon Sales by Type (2019-2024) & (K Units)
Table 45. APAC Peripheral Drug-Coated Balloon Sales by Application (2019-2024) & (K Units)
Table 46. Europe Peripheral Drug-Coated Balloon Sales by Country (2019-2024) & (K Units)
Table 47. Europe Peripheral Drug-Coated Balloon Sales Market Share by Country (2019-2024)
Table 48. Europe Peripheral Drug-Coated Balloon Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Peripheral Drug-Coated Balloon Revenue Market Share by Country (2019-2024)
Table 50. Europe Peripheral Drug-Coated Balloon Sales by Type (2019-2024) & (K Units)
Table 51. Europe Peripheral Drug-Coated Balloon Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Peripheral Drug-Coated Balloon Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Peripheral Drug-Coated Balloon Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Peripheral Drug-Coated Balloon
Table 59. Key Market Challenges & Risks of Peripheral Drug-Coated Balloon
Table 60. Key Industry Trends of Peripheral Drug-Coated Balloon
Table 61. Peripheral Drug-Coated Balloon Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Peripheral Drug-Coated Balloon Distributors List
Table 64. Peripheral Drug-Coated Balloon Customer List
Table 65. Global Peripheral Drug-Coated Balloon Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Peripheral Drug-Coated Balloon Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Peripheral Drug-Coated Balloon Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Peripheral Drug-Coated Balloon Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Peripheral Drug-Coated Balloon Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Peripheral Drug-Coated Balloon Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Peripheral Drug-Coated Balloon Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Peripheral Drug-Coated Balloon Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Peripheral Drug-Coated Balloon Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Peripheral Drug-Coated Balloon Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Peripheral Drug-Coated Balloon Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Peripheral Drug-Coated Balloon Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Peripheral Drug-Coated Balloon Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Peripheral Drug-Coated Balloon Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Cordis Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 80. Cordis Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 81. Cordis Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Cordis Main Business
Table 83. Cordis Latest Developments
Table 84. Defibtech Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 85. Defibtech Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 86. Defibtech Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Defibtech Main Business
Table 88. Defibtech Latest Developments
Table 89. Abbott Laboratories Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 90. Abbott Laboratories Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 91. Abbott Laboratories Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Abbott Laboratories Main Business
Table 93. Abbott Laboratories Latest Developments
Table 94. REVA Medical Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 95. REVA Medical Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 96. REVA Medical Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. REVA Medical Main Business
Table 98. REVA Medical Latest Developments
Table 99. Shimadzu Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 100. Shimadzu Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 101. Shimadzu Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. Shimadzu Main Business
Table 103. Shimadzu Latest Developments
Table 104. Opto Circuits Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 105. Opto Circuits Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 106. Opto Circuits Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. Opto Circuits Main Business
Table 108. Opto Circuits Latest Developments
Table 109. Biotronik Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 110. Biotronik Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 111. Biotronik Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Biotronik Main Business
Table 113. Biotronik Latest Developments
Table 114. Endologix Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 115. Endologix Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 116. Endologix Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. Endologix Main Business
Table 118. Endologix Latest Developments
Table 119. SMT Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 120. SMT Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 121. SMT Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. SMT Main Business
Table 123. SMT Latest Developments
Table 124. Philips Healthcare Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 125. Philips Healthcare Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 126. Philips Healthcare Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. Philips Healthcare Main Business
Table 128. Philips Healthcare Latest Developments
Table 129. Elixir Medical Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 130. Elixir Medical Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 131. Elixir Medical Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. Elixir Medical Main Business
Table 133. Elixir Medical Latest Developments
Table 134. CorMatrix Cardiovascular Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 135. CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 136. CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 137. CorMatrix Cardiovascular Main Business
Table 138. CorMatrix Cardiovascular Latest Developments
Table 139. Advanced Cardiac Therapeutics Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 140. Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 141. Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 142. Advanced Cardiac Therapeutics Main Business
Table 143. Advanced Cardiac Therapeutics Latest Developments
Table 144. Edwards Lifesciences Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 145. Edwards Lifesciences Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 146. Edwards Lifesciences Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 147. Edwards Lifesciences Main Business
Table 148. Edwards Lifesciences Latest Developments
Table 149. Impulse Dynamics Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 150. Impulse Dynamics Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 151. Impulse Dynamics Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 152. Impulse Dynamics Main Business
Table 153. Impulse Dynamics Latest Developments
Table 154. Stereotaxis Basic Information, Peripheral Drug-Coated Balloon Manufacturing Base, Sales Area and Its Competitors
Table 155. Stereotaxis Peripheral Drug-Coated Balloon Product Portfolios and Specifications
Table 156. Stereotaxis Peripheral Drug-Coated Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 157. Stereotaxis Main Business
Table 158. Stereotaxis Latest Developments
LIST OF FIGURES
Figure 1. Picture of Peripheral Drug-Coated Balloon
Figure 2. Peripheral Drug-Coated Balloon Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Peripheral Drug-Coated Balloon Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Peripheral Drug-Coated Balloon Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Peripheral Drug-Coated Balloon Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Paclitaxel
Figure 10. Product Picture of Sirolimus
Figure 11. Product Picture of Others
Figure 12. Global Peripheral Drug-Coated Balloon Sales Market Share by Type in 2023
Figure 13. Global Peripheral Drug-Coated Balloon Revenue Market Share by Type (2019-2024)
Figure 14. Peripheral Drug-Coated Balloon Consumed in Hospital
Figure 15. Global Peripheral Drug-Coated Balloon Market: Hospital (2019-2024) & (K Units)
Figure 16. Peripheral Drug-Coated Balloon Consumed in Clinic
Figure 17. Global Peripheral Drug-Coated Balloon Market: Clinic (2019-2024) & (K Units)
Figure 18. Peripheral Drug-Coated Balloon Consumed in Others
Figure 19. Global Peripheral Drug-Coated Balloon Market: Others (2019-2024) & (K Units)
Figure 20. Global Peripheral Drug-Coated Balloon Sales Market Share by Application (2023)
Figure 21. Global Peripheral Drug-Coated Balloon Revenue Market Share by Application in 2023
Figure 22. Peripheral Drug-Coated Balloon Sales Market by Company in 2023 (K Units)
Figure 23. Global Peripheral Drug-Coated Balloon Sales Market Share by Company in 2023
Figure 24. Peripheral Drug-Coated Balloon Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Peripheral Drug-Coated Balloon Revenue Market Share by Company in 2023
Figure 26. Global Peripheral Drug-Coated Balloon Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Peripheral Drug-Coated Balloon Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Peripheral Drug-Coated Balloon Sales 2019-2024 (K Units)
Figure 29. Americas Peripheral Drug-Coated Balloon Revenue 2019-2024 ($ Millions)
Figure 30. APAC Peripheral Drug-Coated Balloon Sales 2019-2024 (K Units)
Figure 31. APAC Peripheral Drug-Coated Balloon Revenue 2019-2024 ($ Millions)
Figure 32. Europe Peripheral Drug-Coated Balloon Sales 2019-2024 (K Units)
Figure 33. Europe Peripheral Drug-Coated Balloon Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Peripheral Drug-Coated Balloon Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Peripheral Drug-Coated Balloon Revenue 2019-2024 ($ Millions)
Figure 36. Americas Peripheral Drug-Coated Balloon Sales Market Share by Country in 2023
Figure 37. Americas Peripheral Drug-Coated Balloon Revenue Market Share by Country in 2023
Figure 38. Americas Peripheral Drug-Coated Balloon Sales Market Share by Type (2019-2024)
Figure 39. Americas Peripheral Drug-Coated Balloon Sales Market Share by Application (2019-2024)
Figure 40. United States Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Peripheral Drug-Coated Balloon Sales Market Share by Region in 2023
Figure 45. APAC Peripheral Drug-Coated Balloon Revenue Market Share by Regions in 2023
Figure 46. APAC Peripheral Drug-Coated Balloon Sales Market Share by Type (2019-2024)
Figure 47. APAC Peripheral Drug-Coated Balloon Sales Market Share by Application (2019-2024)
Figure 48. China Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Peripheral Drug-Coated Balloon Sales Market Share by Country in 2023
Figure 56. Europe Peripheral Drug-Coated Balloon Revenue Market Share by Country in 2023
Figure 57. Europe Peripheral Drug-Coated Balloon Sales Market Share by Type (2019-2024)
Figure 58. Europe Peripheral Drug-Coated Balloon Sales Market Share by Application (2019-2024)
Figure 59. Germany Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Peripheral Drug-Coated Balloon Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Application (2019-2024)
Figure 68. Egypt Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Peripheral Drug-Coated Balloon in 2023
Figure 74. Manufacturing Process Analysis of Peripheral Drug-Coated Balloon
Figure 75. Industry Chain Structure of Peripheral Drug-Coated Balloon
Figure 76. Channels of Distribution
Figure 77. Global Peripheral Drug-Coated Balloon Sales Market Forecast by Region (2025-2030)
Figure 78. Global Peripheral Drug-Coated Balloon Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Peripheral Drug-Coated Balloon Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Peripheral Drug-Coated Balloon Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Peripheral Drug-Coated Balloon Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Peripheral Drug-Coated Balloon Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Peripheral Drug-Coated Balloon
Figure 2. Peripheral Drug-Coated Balloon Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Peripheral Drug-Coated Balloon Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Peripheral Drug-Coated Balloon Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Peripheral Drug-Coated Balloon Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Paclitaxel
Figure 10. Product Picture of Sirolimus
Figure 11. Product Picture of Others
Figure 12. Global Peripheral Drug-Coated Balloon Sales Market Share by Type in 2023
Figure 13. Global Peripheral Drug-Coated Balloon Revenue Market Share by Type (2019-2024)
Figure 14. Peripheral Drug-Coated Balloon Consumed in Hospital
Figure 15. Global Peripheral Drug-Coated Balloon Market: Hospital (2019-2024) & (K Units)
Figure 16. Peripheral Drug-Coated Balloon Consumed in Clinic
Figure 17. Global Peripheral Drug-Coated Balloon Market: Clinic (2019-2024) & (K Units)
Figure 18. Peripheral Drug-Coated Balloon Consumed in Others
Figure 19. Global Peripheral Drug-Coated Balloon Market: Others (2019-2024) & (K Units)
Figure 20. Global Peripheral Drug-Coated Balloon Sales Market Share by Application (2023)
Figure 21. Global Peripheral Drug-Coated Balloon Revenue Market Share by Application in 2023
Figure 22. Peripheral Drug-Coated Balloon Sales Market by Company in 2023 (K Units)
Figure 23. Global Peripheral Drug-Coated Balloon Sales Market Share by Company in 2023
Figure 24. Peripheral Drug-Coated Balloon Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Peripheral Drug-Coated Balloon Revenue Market Share by Company in 2023
Figure 26. Global Peripheral Drug-Coated Balloon Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Peripheral Drug-Coated Balloon Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Peripheral Drug-Coated Balloon Sales 2019-2024 (K Units)
Figure 29. Americas Peripheral Drug-Coated Balloon Revenue 2019-2024 ($ Millions)
Figure 30. APAC Peripheral Drug-Coated Balloon Sales 2019-2024 (K Units)
Figure 31. APAC Peripheral Drug-Coated Balloon Revenue 2019-2024 ($ Millions)
Figure 32. Europe Peripheral Drug-Coated Balloon Sales 2019-2024 (K Units)
Figure 33. Europe Peripheral Drug-Coated Balloon Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Peripheral Drug-Coated Balloon Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Peripheral Drug-Coated Balloon Revenue 2019-2024 ($ Millions)
Figure 36. Americas Peripheral Drug-Coated Balloon Sales Market Share by Country in 2023
Figure 37. Americas Peripheral Drug-Coated Balloon Revenue Market Share by Country in 2023
Figure 38. Americas Peripheral Drug-Coated Balloon Sales Market Share by Type (2019-2024)
Figure 39. Americas Peripheral Drug-Coated Balloon Sales Market Share by Application (2019-2024)
Figure 40. United States Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Peripheral Drug-Coated Balloon Sales Market Share by Region in 2023
Figure 45. APAC Peripheral Drug-Coated Balloon Revenue Market Share by Regions in 2023
Figure 46. APAC Peripheral Drug-Coated Balloon Sales Market Share by Type (2019-2024)
Figure 47. APAC Peripheral Drug-Coated Balloon Sales Market Share by Application (2019-2024)
Figure 48. China Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Peripheral Drug-Coated Balloon Sales Market Share by Country in 2023
Figure 56. Europe Peripheral Drug-Coated Balloon Revenue Market Share by Country in 2023
Figure 57. Europe Peripheral Drug-Coated Balloon Sales Market Share by Type (2019-2024)
Figure 58. Europe Peripheral Drug-Coated Balloon Sales Market Share by Application (2019-2024)
Figure 59. Germany Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Peripheral Drug-Coated Balloon Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Application (2019-2024)
Figure 68. Egypt Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Peripheral Drug-Coated Balloon Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Peripheral Drug-Coated Balloon in 2023
Figure 74. Manufacturing Process Analysis of Peripheral Drug-Coated Balloon
Figure 75. Industry Chain Structure of Peripheral Drug-Coated Balloon
Figure 76. Channels of Distribution
Figure 77. Global Peripheral Drug-Coated Balloon Sales Market Forecast by Region (2025-2030)
Figure 78. Global Peripheral Drug-Coated Balloon Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Peripheral Drug-Coated Balloon Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Peripheral Drug-Coated Balloon Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Peripheral Drug-Coated Balloon Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Peripheral Drug-Coated Balloon Revenue Market Share Forecast by Application (2025-2030)
